This edition of HDYO Research Video Series features the HD Buzz Article reviewing the latest news about the uniQure trial looking at AMT-130.

uniQure ushered in the end of 2023 by releasing some promising data from their huntingtin-lowering gene therapy trials.

To read the full article, visit: https://en.hdbuzz.net/355

The Research Video Series is sponsored by Teva Pharmaceuticals, uniQure, Wave Life Sciences, Sage Therapeutics, Griffin Foundation, Roche and Neurocrine Biosciences.